ABSTRACT
In cases of sepsis, a timely microbiological diagnosis including data on 28 antimicrobial susceptibility is crucial to allow the prompt initiation of a targeted 29 therapy (1). This is not possible with currently used methods, thus causing a 30 significant delay in specific treatment and the empirical use of broad-spectrum 31 antimicrobials (2-4). Nucleic-acid-based assays are considered as a potential 32 adjuvant tool in improving the microbiological diagnosis of sepsis (5-7). These assays 33 may be classified in two groups (5-7): (i) those on positive blood cultures, potentially 34 useful but burdened by usual culture-associated drawbacks (i.e. interfering effect of 35 ongoing antibiotics; long time-to-positivity; presence of fastidious pathogens); and 36 (ii) those on blood samples, promising but still not developed for the sensitive 37 detection of resistance markers (5-7). 38 In this pilot study, we evaluated the Verigene Gram-negative blood culture 39 (BC-GN) test (Nanosphere, Northbrook, IL, USA), a microarray-based, almost fully 40 automated, random-access system allowing bacterial identification (Table 1) and 41 detection of several resistance genes (Table 2) was later confirmed by dAST (Table 3) . CTX-M genes were confirmed in all isolates by PCR and sequencing, including two isolates featuring a negative DDST (Table 3) .
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In particular, a single CTX-M-positive isolate by BC-GN did not show an ESBL-91 producing phenotype neither by dAST nor by DDST although confirming the 92 presence of a CTX-M-9 gene by PCR amplification and sequencing (Table 3) . 93 Importantly, all nine isolates positive for KPC genes showed an antibiotic 94 susceptibility phenotype by pAST compatible to the production of carbapenemases, 95 eventually confirmed by PBA and dAST ( 
